Description
Recombinant monoclonal antibody to ICOS. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 7E.17G9. This chimeric mouse antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques.
Target
ICOS
Target Alias Names
CD278, AILIM, CVID1, inducible T-cell co-stimulator, inducible T-cell costimulator, 7E.17G9.G1.G7
Isotype/Mimetic
IgG2b
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression